Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, variants, or PubMed publications.

Have questions, comments or suggestions? - Let us know!

Email us at : ckbsupport@jax.org

NCT ID NCT01798485
Title A Phase 3 Study of Ganetespib in Combination With Docetaxel Versus Docetaxel Alone in Patients With Advanced NSCLC
Recruitment Terminated
Gender both
Phase Phase III
Variant Requirements Yes
Sponsors Synta Pharmaceuticals Corp.
Indications

lung non-small cell carcinoma

Therapies

Ganetespib

Docetaxel

Age Groups: adult
Covered Countries USA | ITA | FRA | ESP | DEU | CAN | BEL | AUT

Additional content available in CKB BOOST